NCT06693284
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06693284
Title A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Minnesota
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.